AWS Launches Amazon Bio Discovery Agentic AI to Accelerate Drug Development
AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery and brings enterprise-grade scale, privacy, and security to life science research. The post AWS Launches Amazon Bio Discovery Agentic AI to Accelerate Drug Development appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.